Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gary Steven Sachs, M.D.

Co-Author

This page shows the publications co-authored by Gary Sachs and S Nassir Ghaemi.
Connection Strength

1.481
  1. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants. Psychiatr Serv. 2006 May; 57(5):660-5.
    View in: PubMed
    Score: 0.340
  2. The treatment of bipolar depression. Bipolar Disord. 2000 Sep; 2(3 Pt 2):256-60.
    View in: PubMed
    Score: 0.230
  3. Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol. 1997 Nov; 12(6):333-8.
    View in: PubMed
    Score: 0.189
  4. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry. 2010 Apr; 71(4):372-80.
    View in: PubMed
    Score: 0.111
  5. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2007 Oct; 68(10):1472-9.
    View in: PubMed
    Score: 0.094
  6. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002 Jul; 159(7):1146-54.
    View in: PubMed
    Score: 0.065
  7. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2000 Sep; 61(9):638-42.
    View in: PubMed
    Score: 0.057
  8. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999 Jan-Mar; 52(1-3):135-44.
    View in: PubMed
    Score: 0.051
  9. Insight in seasonal affective disorder. Compr Psychiatry. 1997 Nov-Dec; 38(6):345-8.
    View in: PubMed
    Score: 0.047
  10. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry. 1997 Mar; 42(2):196-9.
    View in: PubMed
    Score: 0.045
  11. Akathisia: a review and case report following paroxetine treatment. Compr Psychiatry. 1996 Mar-Apr; 37(2):122-4.
    View in: PubMed
    Score: 0.042
  12. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013 Nov; 170(11):1249-62.
    View in: PubMed
    Score: 0.036
  13. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009 Aug; 11(5):453-73.
    View in: PubMed
    Score: 0.027
  14. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry. 2009 Feb; 70(2):155-62.
    View in: PubMed
    Score: 0.026
  15. Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients. J Affect Disord. 2008 Dec; 111(2-3):372-7.
    View in: PubMed
    Score: 0.025
  16. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007 Sep; 164(9):1348-55.
    View in: PubMed
    Score: 0.023
  17. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. J Clin Psychiatry. 2006 Mar; 67(3):394-9.
    View in: PubMed
    Score: 0.021
  18. Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord. 2005 Oct; 7(5):465-70.
    View in: PubMed
    Score: 0.020
  19. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry. 2004 Apr; 184:337-45.
    View in: PubMed
    Score: 0.018
  20. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review. Ann Clin Psychiatry. 2000 Sep; 12(3):137-40.
    View in: PubMed
    Score: 0.014
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.